Table 2.
Sample | 2D | 3D | Wt 10 nM | Wt 50 nM | mAb13 | mAb13 +Wt 10 nM | mAb13 Wt 50 nM |
---|---|---|---|---|---|---|---|
untreated | |||||||
Ctrl | < 0.0001*** | - | 0.0016** | < 0.0001*** | < 0.0001*** | < 0.0001*** | < 0.0001*** |
TA | < 0.0001*** | < 0.0001*** | 0.5975 | < 0.0001*** | < 0.0001*** | < 0.0001*** | < 0.0001*** |
Wt 10 nM | |||||||
Ctrl | - | - | - | 0.1902 | 0.0221** | 0.0009*** | < 0.0001*** |
TA | - | - | - | < 0.0001*** | < 0.0001*** | < 0.0001*** | < 0.0001*** |
Wt 50 nM | |||||||
Ctrl | - | - | - | - | 0.2022 | 0.0042** | < 0.0001*** |
TA | - | - | - | - | 0.0005*** | < 0.0001*** | < 0.0001*** |
mAb13 | |||||||
Ctrl | - | - | - | - | - | 0.1687 | 0.0005*** |
TA | - | - | - | - | - | 0.4596 | 0.0108* |
mAb13 + Wt 10 nM | |||||||
Ctrl | - | - | - | - | - | - | 0.0686 |
TA | - | - | - | - | - | - | 0.0742 |
P values were obtained using Mann-Whitney test. Non-significant values are underlined while relative significance levels are designated as extremely***, very**, or significant*. Bolded data represent conditions in which differences were observed between control and tumor-associated 3D matrix induced EFF due to stated treatments.